1. Home
  2. Analysis
  3. Mevacor
  4. Zoledronic-acid

Mevacor and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 10 people who take Mevacor and Zoledronic acid. Common interactions include disease progression among females, and fatigue among males.

The phase IV clinical study analyzes what interactions people who take Mevacor and Zoledronic acid have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 25, 2023

10 people who take Mevacor and Zoledronic acid together, and have interactions are studied.

What is Mevacor?

Mevacor has active ingredients of lovastatin. It is used in high blood cholesterol. Currently, eHealthMe is studying from 4,969 Mevacor users.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. Currently, eHealthMe is studying from 25,642 Zoledronic acid users.

Number of Mevacor and Zoledronic acid reports submitted per year:

Mevacor and Zoledronic acid drug interactions.

Common Mevacor and Zoledronic Acid drug interactions by gender *:

female:

  1. Disease progression
  2. Haemorrhage
  3. Iron deficiency anaemia
  4. Osteoporosis
  5. Pain
  6. Plasma cell myeloma
  7. Visual impairment
  8. Neoplasm malignant
  9. Hypoaesthesia
  10. Type 2 diabetes mellitus

male:

  1. Fatigue
  2. Headache
  3. Plasma cell myeloma
  4. Pulmonary haemorrhage
  5. Respiratory failure

Common Mevacor and Zoledronic Acid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaemia
  2. Chronic kidney disease
  3. Compression fracture
  4. Disease progression
  5. Dry mouth
  6. Haemorrhage
  7. Iron deficiency anaemia
  8. Macular degeneration
  9. Osteoporosis
  10. Pain

60+:

  1. Plasma cell myeloma
  2. Anaemia
  3. Pain
  4. Neoplasm malignant
  5. Visual impairment
  6. Ageusia
  7. Fatigue
  8. Headache
  9. Hypoaesthesia
  10. Pulmonary haemorrhage

Common conditions people have *:

  1. Pain: 8 people, 80.00%
  2. Nausea (feeling of having an urge to vomit): 8 people, 80.00%
  3. Wheezing (a high-pitched whistling sound made while you breath): 7 people, 70.00%
  4. Breathing Difficulty: 7 people, 70.00%
  5. Neuropathy Peripheral (surface nerve damage): 7 people, 70.00%
  6. Thalamic Infarction (tissue death of thalamus part of brain): 6 people, 60.00%
  7. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 60.00%
  8. Hypoaesthesia (reduced sense of touch or sensation): 5 people, 50.00%
  9. Back Pain: 5 people, 50.00%
  10. Muscle Spasms (muscle contraction): 5 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mevacor and Zoledronic acid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Mevacor side effects:

Browse all side effects of Mevacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zoledronic acid side effects:

Browse all side effects of Zoledronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mevacor interactions:

Browse all interactions between Mevacor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zoledronic acid interactions:

Browse all interactions between Zoledronic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin and zoledronic acid (the active ingredients of Mevacor and Zoledronic acid, respectively), and Mevacor and Zoledronic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mevacor and Zoledronic acid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.